Terms ending in 2040
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,553,896 | Distance-Based Tissue State Determination In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,709,605 | Novel Pyridine and Pyrazine Compounds as Inhibitors of Cannabinoid Receptor 2 In force · Medium confidence | Eth Zuerich | In force | Medium confidence | |
| US 11,672,858 | Bispecific Antibody Molecules Binding to CD3 and TYRP-1 In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,679,127 | ANTIGEN BINDING RECEPTORS SPECIFIC FOR MUTATED Fc DOMAINS In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,390,604 | Novel Imidazole-Pyrazole Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,680,110 | Three-Dimensional Structure-Based Humanization Method In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,473,042 | Monitoring state deviations in bioreactors In force · High confidence | Hoffmann-La Roche, Inc. | In force | High confidence | |
| US 12,000,064 | Universal Reporter Cell Assay for Specificity Test of Novel Antigen Binding Moieties In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,866,490 | Antibody That Binds to VEGF and IL-1BETA and Methods of Use In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,873,302 | Solid Forms of a Compound of HBV Core Protein Allosteric Modifier In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 26 more term ends in 2040 · Pro | |||||
10 of 36 patents shown. Soonest term end first, then patent number.
Pro members see all 36.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.